Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid for Free Flap Reconstructive Surgery
NCT05327348Phase 3Unknown
- Sponsor
- Universiti Malaya
- Start
- Sep 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid in ischemia-reperfusion injury (IRI), sponsored by Universiti Malaya. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT05327348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327348.